Chloromed 150 mg/g Premix for Medicated Feeding Stuff for Pigs

Nchi: Uingereza

Lugha: Kiingereza

Chanzo: VMD (Veterinary Medicines Directorate)

Viambatanisho vya kazi:

Chlortetracycline Hydrochloride

Inapatikana kutoka:

Univet Ltd

ATC kanuni:

QJ01AA03

INN (Jina la Kimataifa):

Chlortetracycline Hydrochloride

Dawa fomu:

Premix for medicated feeding stuff

Dawa ya aina:

POM-V - Prescription Only Medicine – Veterinarian

Kundi la matibabu:

Pigs

Eneo la matibabu:

Antimicrobial

Idhini hali ya:

Authorized

Idhini ya tarehe:

2011-01-14

Tabia za bidhaa

Revised: June 2016
AN: 01047/2015
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Chloromed 150 mg/g premix for medicated feeding stuff for Pigs.
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each g contains
ACTIVE SUBSTANCE:
Chlortetracycline hydrochloride 150 mg
EXCIPIENTS:
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Premix for medicated feeding stuff
A coarse, yellow powder.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Pigs
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Pigs:
The product is indicated in the treatment of respiratory disease in
pigs caused by micro-
organisms sensitive to chlortetracycline
4.3
CONTRAINDICATIONS
Do not use in animals with known hypersensitivity to tetracycline.
Do not use in animals with severe liver and renal disorders.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
The uptake of oral medication by animals can be altered as a
consequence of illness. In
case of insufficient uptake of feed, animals should be treated
parenterally.
Revised: June 2016
AN: 01047/2015
Page 2 of 5
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
The product is efficient only against bacterial strains most sensitive
to chlortetracycline.
Use of the product should be based on susceptibility testing of the
bacteria isolated from
the animal. If this is not possible, therapy should be based on local
(regional, farm level)
epidemiological information about susceptibility of the target
bacteria
Inappropriate use of the product may increase the prevalence of
bacteria resistant to
chlortetracycline and may decrease the effectiveness of treatment with
related substances,
due to the potential for cross-resistance.
Long term use of this product is not recommended as it may lead to the
development of
bacterial resistance.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY
MEDICINAL PRODUCT TO ANIMALS
Handle this product with care to avoid exposure when adding to feed
and administering
medicated fee